SCHEMBL13629837

SCHEMBL13629837

CC(=O)C1CCN(C(=O)c2ccccn2)CC1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.69
EPHX2 P34913 3/20 0.59
RIPK1 Q13546 1/20 0.57
RBP4 P02753 1/20 0.56
CHRNB2 P17787 1/20 0.52
CHRNB4 P30926 1/20 0.52
CHRNA3 P32297 1/20 0.52
CHRNA7 P36544 1/20 0.52
CHRNA4 P43681 1/20 0.52
EPHX1 P07099 2/20 0.51
PLA2G1B P04054 1/20 0.50
ATG4B Q9Y4P1 1/20 0.50
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NAMPT P43490 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
GAA P10253 2/20 0.48
PDE10A Q9Y233 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13744784 0.85 L3MBTL1 (0.73) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL22972208 0.83 L3MBTL1 (0.75) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL7943306 0.82 L3MBTL1 (1.00) L3MBTL1EPHX2RBP4CHRNB2CHRNB4
SCHEMBL16003044 0.81 EPHX2 (0.68) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL28448703 0.81 L3MBTL1 (0.62) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL29500884 0.80 MEN1 (0.57) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL21061661 0.80 MEN1 (0.57) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL14197785 0.79 L3MBTL1 (0.64) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL28467307 0.79 L3MBTL1 (0.69) L3MBTL1EPHX2RIPK1RBP4CHRNB2
SCHEMBL2224365 0.79 L3MBTL1 (0.69) L3MBTL1EPHX2RIPK1RBP4CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3456711-A1 CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2019-03-20 EP disclosed
US-7622487-B2 Piperidine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-24 US disclosed
US-7622487-B2 Piperidine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-24 US disclosed